Adipose tissue in our body stores fat. At some point prolonged eating of a diet that is too high in fats leads to storage of these fats in other places, like muscle and liver.
This can lead to fatty liver disease, insulin resistance, and ultimately type 2 diabetes mellitus. Researchers have known for some time that this process involves a specific group of fats known as ceramides. These are produced in the body by various ceramide synthases.
„Other research groups have already shown that blocking ceramide production in mice prevents the development of insulin resistance. However, this is associated with a large number of side effects. If, for example, ceramide synthesis is completely inhibited it can adversely affect the development of the animals,“ explains Philipp Hammerschmidt, a doctoral student in Brüning’s research group and first author of the study. The researchers, therefore, investigated precisely which of the various ceramide synthases are involved in the development of insulin resistance, in the hope of providing more specific therapeutic targets.
They discovered that ceramide molecules of a particular length, formed by both ceramide synthases 5 and 6, accumulate in the liver when mice become obese on a high-fat diet. “Interestingly, only the genetic inactivation of ceramide synthase 6 in mice, resulted in protection from obesity, fatty liver, and insulin resistance. However, losing ceramide synthase 5 activity, did not have these effects“, explains Hammerschmidt.
Same product – different function
„This was very surprising, as these two synthases produce exactly the same ceramide product but have completely different effects on the metabolism of the mice,“ said Hammerschmidt. The scientists discovered that the two proteins are active at different locations within the cell. Ceramide synthase 6 regulates the ceramide content in mitochondria, the cell’s energy generators, influencing their structure and function.
The fact that the mice become overweight and unhealthy on a poor diet is, probably, in part due to the accumulation of ceramides formed by ceramide synthase 6, in mitochondria. This leads to impairment of their function. The discovery allowed the researchers to identify key proteins in mitochondria, which bind ceramides specifically from ceramide synthase 6 but not ceramides from the related ceramide synthase 5.
Switching off ceramide synthase 6 in a precisely controlled way resulted in a clear effect: “The mice continue eating the high-fat diet, nevertheless their glucose metabolism improves,“ explains Hammerschmidt. „It’s possible that inhibition of ceramide synthase 6, or the ceramide-binding mitochondrial proteins we found, could be used as a basis for therapies in humans, but there is still a long way to go.”
contact for scientific information:
Jens Brüning, Director Max Planck Institute for Metabolism Research, email@example.com
Philipp Hammerschmidt, Daniela Ostkotte, Hendrik Nolte, Mathias J. Gerl, Alexander Jais, Hanna L. Brunner, Hans-Georg Sprenger, Motoharu Awazawa, Hayley T. Nicholls, Sarah M. Turpin-Nolan, Thomas Langer, Marcus Krüger, Britta Brügger, and Jens C. Brüning
CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity
Cell, May 30, 2019